These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 2134685)

  • 1. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous and endogenous DNA modifications as monitored by 32P-postlabeling: relationships to cancer and aging.
    Randerath K; Li D; Nath R; Randerath E
    Exp Gerontol; 1992; 27(5-6):533-49. PubMed ID: 1426086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin.
    Randerath E; Avitts TA; Reddy MV; Miller RH; Everson RB; Randerath K
    Cancer Res; 1986 Nov; 46(11):5869-77. PubMed ID: 3756927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from coke oven workers: correlation with job categories.
    Ovrebø S; Haugen A; Phillips DH; Hewer A
    Cancer Res; 1992 Mar; 52(6):1510-4. PubMed ID: 1540959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K; Randerath E; Agrawal HP; Reddy MV
    IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
    Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
    Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
    Lu LJ; Disher RM; Reddy MV; Randerath K
    Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: application to unidentified genotoxicants.
    Randerath K; Miller RH; Mittal D; Randerath E
    IARC Sci Publ; 1988; (89):361-7. PubMed ID: 3198221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
    Li D; Wang M; Dhingra K; Hittelman WN
    Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
    Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
    Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of DNA adducts in human oral tissue: correlation of adduct levels with tobacco smoking and differential enhancement of adducts using the butanol extraction and nuclease P1 versions of 32P postlabeling.
    Jones NJ; McGregor AD; Waters R
    Cancer Res; 1993 Apr; 53(7):1522-8. PubMed ID: 8453617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatic DNA adducts in white blood cells of foundry workers.
    Hemminki K; Perera FP; Phillips DH; Randerath K; Reddy MV; Santella RM
    IARC Sci Publ; 1988; (89):190-5. PubMed ID: 3143668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for testing compounds for DNA adduct formation.
    Reddy MV
    Regul Toxicol Pharmacol; 2000 Dec; 32(3):256-63. PubMed ID: 11162719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
    Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
    Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.